Pernock David Insider Trades

Insider Trading History

Track insider trading activity for Pernock David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres & Chief Operating Officer
Holding Value $25.1k 54,625 shares
Last Trade
Feb 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$478k 9,700 shares
$49.32
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres & Chief Operating Officer
Holding Value $20.7k 44,925 shares
Last Trade
Jan 23, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$90.2k 1,892 shares
$47.70
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres & Chief Operating Officer
Holding Value $21.5k 46,817 shares
Last Trade
Jan 07, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$46.2k 906 shares
$50.97
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres & Chief Operating Officer
Holding Value $22k 47,723 shares
Last Trade
Jan 05, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$104k 2,088 shares
$50.02
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres. & Chief Comm. Officer
Holding Value $22.9k 49,811 shares
Last Trade
Jan 23, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$104k 1,793 shares
$57.98
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres. & Chief Comm. Officer
Holding Value $23.7k 51,604 shares
Last Trade
Jan 07, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$51.9k 904 shares
$57.38
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres. & Chief Comm. Officer
Holding Value $24.2k 52,508 shares
Last Trade
Jan 05, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.34M 72,500 shares
$59.80
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres. & Chief Comm. Officer
Holding Value $21.4k 46,600 shares
Last Trade
Jan 23, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.86M 67,500 shares
$42.40
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres. & Chief Comm. Officer
Holding Value $4.65k 10,108 shares
Last Trade
Jan 07, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$35.5k 858 shares
$41.33
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres. & Chief Comm. Officer
Holding Value $23k 50,000 shares
Last Trade
Jan 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.32M 90,000 shares
$59.14
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres. & Chief Comm. Officer
Holding Value $444 966 shares
Last Trade
May 19, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20.3k 255 shares
$79.69
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres. & Chief Comm. Officer
Holding Value $327 711 shares
Last Trade
May 16, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$16.4k 200 shares
$82.24
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres. & Chief Comm. Officer
Holding Value $235 511 shares
Last Trade
Mar 21, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.12k 61 shares
$83.98
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres. & Chief Comm. Officer
Holding Value $207 450 shares
Last Trade
Mar 09, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$35k 450 shares
$77.84
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Pres. & Chief Comm. Officer
Holding Value $41.4k 90,000 shares
Last Trade
Jan 04, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.64M 90,000 shares
$84.92
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Director
Holding Value $6.9k 15,000 shares
Last Trade
Jan 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.29M 15,000 shares
$86.15
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Director
Holding Value $6.9k 15,000 shares
Last Trade
Apr 21, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$890k 15,000 shares
$59.31
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Director
Holding Value $4.6k 10,000 shares
Last Trade
Apr 21, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$593k 10,000 shares
$59.31
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Director
Holding Value $4.6k 10,000 shares
Last Trade
Apr 08, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$468k 10,000 shares
$46.81
$0.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up